Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 Last 

Alabama

Rheumatology Associates of North Alabama, PC
Huntsville Alabama 35801

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Arizona

Arizona Arthritis & Rheumatology Research, PLLC
Glendale Arizona 85304

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Arizona Research Center
Phoenix Arizona 85023

A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214(Study Medication) Versus Enbrel in Subjects With Chronic Plaque Psoriasis.

California

Medvin Clinical Research
Covina California 91723

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare
Fullerton California 92835

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

University of California, Irvine Dermatology Clinical Research Center
Irvine California

A Multi-Center, Open Label, Phase 1 Study to Evaluate the Safety of Both A Prospective, Observational Study to Estimate the Proportion of Subjects with Plaque Psoriasis who Achieve Complete Clearance on Biologics

University of California, Irvine Dermatology Clinical Research Center
Irvine California 92697

Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects with Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab

Dermatology Research Associates
Los Angeles California 90045

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

Dermatology Specialists, Inc.
Oceanside California 92056

A national, multi-center, randomized, double-blind, 4 arm, 8 week study in subjects with psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs)

Dermatology Specialists, Inc.
Oceanside California 92056

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Dermatology Specialists, Inc.
Oceanside California 92056

You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis

San Diego Arthritis Medical Clinic
San Diego California 92108

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

MedDerm Associates
San Diego California 92103

Do you have plaque-type psoriasis?

Connecticut

New England Research Associates, LLC
Trumbull Connecticut 06611

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Florida

Rheumatology Associates of Central Florida, PA
Orlando Florida 32806

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Millennium Research
Ormond Beach Florida 32174

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Arthritis Center, Inc.
Palm Harbor Florida 34684

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

University of South Florida - Morsani Center for Advance Healthcare
Tampa Florida 33612

A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis

Olympian Clinical Research
Tampa Florida 33609

Do you have plaque-type psoriasis?

University of South Florida - Morsani Center for Advance Healthcare
Tampa Florida 33612

Effect of Calcipotriol plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 months) with Scalp and Body Psoriasis

Georgia

Advanced Medical Research, Inc.
Atlanta Georgia 30342

Do you have plaque-type psoriasis?

Advanced Medical Research, Inc.
Atlanta Georgia 30342

Do you have plaque-type psoriasis?

Columbus Regional Research Institute
Columbus Georgia 31904

Considering potential research options for managing psoriasis?

Medaphase, Inc
Newnan Georgia 30263

Do you have plaque-type psoriasis?

Illinois

Northwestern University
Chicago Illinois 60611

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

Indiana

NEW

Dawes Fretzin Clinical Research Group, LLC
Indianapolis Indiana 46256

Do you have moderate-to-severe plaque-type psoriasis?

NEW

Indiana Clinical Trials Center
Plainfield Indiana 46168

Do you have moderate-to-severe plaque-type psoriasis?

Kansas

Professional Research Network of Kansas, LLC
Wichita Kansas 67203

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Kentucky

NEW

Dermatology Specialists
Louisville Kentucky 40202

Do you have moderate-to-severe plaque-type psoriasis?

Bluegrass Community Research, Inc
Lexington Kentucky 40504

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Maryland

Klein & Associates, M.D., P.A.
Hagerstown Maryland 21740

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

The Center For Rheumatology And Bone Research
Wheaton Maryland 20902

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Study Medication in Subjects with Active Psoriatic Arthritis and an Inadequate Response to at Least one TNF Inhibitor

Massachusetts

ORA, Inc
Andover Massachusetts 1810

Do you have plaque-type psoriasis?

First 1 2 3 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.